SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-11-173792
Filing Date
2011-06-27
Accepted
2011-06-27 08:06:33
Documents
11

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K d8k.htm 425 49822
2 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION dex21.htm EX-2.1 732407
3 LETTER AGREEMENT: RONALD MARTEL dex103.htm EX-10.3 12771
4 LETTER AGREEMENT: MICHAEL S. PERRY dex104.htm EX-10.4 8712
5 LETTER AGREEMENT: MICHAEL K. JACKSON dex105.htm EX-10.5 6276
6 LETTER AGREEMENT: CHENI KWOK dex106.htm EX-10.6 8900
7 LETTER AGREEMENT: ANNA L. WIGHT dex107.htm EX-10.7 8744
8 PRESS RELEASE dex991.htm EX-99.1 25074
9 GRAPHIC g200628g56g25.jpg GRAPHIC 7856
10 GRAPHIC g200628g67q84.jpg GRAPHIC 5347
11 GRAPHIC g200628g68t67.jpg GRAPHIC 8737
  Complete submission text file 0001193125-11-173792.txt   885170
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 530 SEATTLE WA 98119-4114
Business Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111 2062862501
PONIARD PHARMACEUTICALS, INC. (Filed by) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 ELLIOTT AVENUE WEST SUITE 530 SEATTLE WA 98119-4114
Business Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111 2062862501
PONIARD PHARMACEUTICALS, INC. (Subject) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-16614 | Film No.: 11931861
SIC: 2834 Pharmaceutical Preparations